
CAS Name: 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
Percent Composition: C 73.70%, H 6.53%, N 14.32%, O 5.45%
Literature References: Specific serotonin (5HT3) receptor antagonist. Prepn: I. H. Coates et al., EP 191562; eidem, US 4695578 (1986, 1987 both to Glaxo). Pharmacology: A. Butler et al., Br. J. Pharmacol. 94, 397 (1988). Clinical trials in cancer chemotherapy-induced nausea and vomiting: M. G. Kris et al., J. Clin. Oncol. 6, 659 (1988); L. Cubeddu et al., N. Engl. J. Med. 322, 810 (1990); M. Marty et al., ibid. 816. Clinical evaluation in treatment of bulimia: P. L. Faris et al., Lancet 355, 792 (2000); in early onset alcoholism: B. A. Johnson et al., J. Am. Med. Assoc. 284, 963 (2000). Review of pharmacology and therapeutic use: A. Markham, E. M. Sorkin, Drugs 45, 931-952 (1993); of clinical pharmacokinetics: K. H. Simpson, F. M. Hicks, J. Pharm. Pharmacol. 48, 774-781 (1996).
CAS Name: 1H-Indole-3-carboxylic acid (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
Additional Names: 3a-tropanyl-1H-indole-3-carboxylic acid ester; 1aH,5aH-tropan-3a-yl indole-3-carboxyl...
Literature References: Specific serotonin (5-HT3) receptor antagonist. Prepn: P. Donatsch et al., DE 3322574 (1983 to Sandoz); idem et al., US 4789673 (1988). Pharmacology: B. P. Richardson et al., Nature 316, 126 (1985); F. M. Williams et al., J. Cardiovasc. Pharmacol. 7, 550 (1985). Receptor binding studies: C. Waeber et al., Neuroscience 31, 393 (1989). Clinical pharmacokinetics: V. Fischer et al., Drug Metab. Dispos. 20, 603 (1992). Series of articles on antiemetic efficacy in chemotherapy and radiotherapy: Drugs 43, Suppl. 3, 6-39 (1992). Review of pharmacology: C. Seynaeve et al., Anti-Cancer Drugs 2, 343-355 (1991); and toxicology: K. Kutz, Ann. Oncol. 4, Suppl. 3, S15-S18 (1993).
CAS Name: 3,4,5-Trihydroxybenzoic acid propyl ester
Additional Names: n-propyl gallate; gallic acid propyl ester; PG
Trademarks: Progallin P (Nipa); Tenox PG (Eastman)
Percent Composition...
Literature References: Spectrophotometric determn: C. S. Sastry et al., Talanta 29, 917 (1982). Effects on survival of Saccharomyces cerevisiae: V. L. Eubanks, L. R. Beuchat, J. Food Prot. 46, 29 (1983). Antioxidant effectiveness: M. A. Augustin, S. K. Berry, J. Am. Oil Chem. Soc. 60, 105 (1983). Comprehensive review of biological effects and toxicology: J. Am. Coll. Toxicol. 4, 23-64 (1985).
CAS Name: 2-Methyl-N-(phenylmethylene)-2-propanamine N-oxide
Additional Names: benzylidene-tert-butylamine oxide; N-tert-butyl-a-phenylnitrone
Percent Composition: C 74.54%, H 8.53%, N 7.90%...
Literature References: Spin trapping agent for short-lived radicals in biological systems. Prepn: W. D. Emmons, J. Am. Chem. Soc. 79, 5739 (1957); R. W. Murray et al., J. Org. Chem. 61, 8099 (1996). Effects on ischemia in brain: J. W. Phillis, C. Clough-Helfman, Med. Sci. Res. 18, 403 (1990); K. Pahlmark, B. K. Siesjö, Acta Physiol. Scand. 157, 41 (1996). Review of chemical properties and biological applications: G. Chen et al. in The Oxygen Paradox, PBN and Its Applications in Biology, K. J. A. Davies, F. Ursini, Eds. (Cleup Press, Italy, 1995) pp. 789-800.
CAS Name: (4'S)-6-Fluoro-2,3-dihydrospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dione
Additional Names: (+)-(4S)-6-fluorospiro[chroman-4,4'-imidazolidine]-2',5'-dionePercent Composition: C ...
Literature References: Spirohydantoin aldose reductase inhibitor. Prepn of racemate and resolution of isomers: R. Sarges, DE 2821966; idem, US 4130714 (both 1978 to Pfizer). Synthesis: R. Sarges et al., J. Org. Chem. 47, 4081 (1982); N. L. Dirlam et al., J. Org. Chem. 52, 3587 (1987). Absolute configuration: R. Sarges et al., J. Med. Chem. 28, 1716 (1985). Effect on polyol accumulation in diabetic rats: M. J. Peterson et al., Metabolism 28, Suppl. 1, 456 (1979). Pharmacokinetics in humans: G. Foulds et al., Clin. Pharmacol. Ther. 30, 693 (1981). HPLC determn in human lens and plasma: P. Lloyd, M. J. C. Crabbe, J. Chromatogr. 343, 402 (1985). Preliminary clinical trials in diabetic neuropathy: R. J. Young et al., Diabetes 32, 938 (1983); J. Jaspan et al., Lancet 2, 758 (1983). Symposium on pharmacology and clinical efficacy: Metabolism 35, Suppl 1, 1-121 (1986).
CAS Name: 8-(1,1-Dimethylethyl)-N-ethyl-N-propyl-1,4-dioxaspiro[4.5]decane-2-methamineTrademarks: Impulse (Bayer)
Percent Composition: C 72.67%, H 11.86%, N 4.71%, O 10.76%
Literature References: Spiroketalamine fungicide for use on cereal crops; inhibits ergosterol synthesis. Prepn: W. Kraemer et al., DE 3735555; eidem, US 4851405 (1988, 1989 both to Bayer). Mode of action and field trials: S. Dutzmann et al., Brighton Crop Prot. Conf. - Pests Dis. 1996, 47. Series of articles on chemistry, activity, determn and ecobiology: Pflanzenschutz-Nachr. 50, 5-98 (1997).
CAS Name: (6-Methoxy-2-pyridinyl)methylcarbamothioic acid O-(5,6,7,8-tetrahydro-2-naphthalenyl) ester
Additional Names: O-5,6,7,8-tetrahydro-2-naphthyl N-(6-methoxy-2-pyridyl)-N-methylthiocarba...
Literature References: Squalene epoxidase inhibitor. Prepn: BE 897021; T. Takematsu et al., US 4554012 (1983, 1985 both to Toyo Soda Manufacturing Co., Ltd.). Mode of action study: T. Morita et al., J. Med. Vet. Mycol. 27, 17 (1989). Antifungal spectrum: K. Iwata et al., Antimicrob. Agents Chemother. 33, 2118 (1989). Physicochemical properties and stability: H. Awano et al., Iyakuhin Kenkyu 23, 558 (1992).
CAS Name: 2,2,6,6-Tetramethyl-1-piperidinyloxy
Additional Names: 2,2,6,6-tetramethylpentamethylene nitroxide
Percent Composition: C 69.18%, H 11.61%, N 8.96%, O 10.24%
Literature References: Stable nitroxide free radical used as reversible capping agent in "living" free radical polymerizations and as catalyst for selective oxidation of alcohols. Prepn: E. G. Ruzantsev et al., Bull. Acad. Sci. USSR Div. Chem. Sci. 1962, 2152. Crystal structure: Z. Ciunik, J. Mol. Struct. 412, 27 (1997). Thermal stability: M. V. Ciriano et al., J. Am. Chem. Soc. 121, 6375 (1999). Effect of acids on reaction rates: M. V. Baldovi et al., Macromolecules 29, 5497 (1996). Use in oxidation of alcohols: M. Zhao et al., J. Org. Chem. 64, 2564 (1999); in production of aminyl radicals: W. Huang et al., J. Am. Chem. Soc. 121, 3939 (1999); in polymerization: L. I. Gabaston et al., Polymer 40, 4505 (1999).
CAS Name: 1,3-Dibromo-5,5-dimethyl-2,4-imidazolidinedione
Additional Names: 1,3-dibromo-5,5-dimethylhydantoin; DBH; DBDMH
Percent Composition: C 21.00%, H 2.12%, Br 55.89%, N 9.80%, O 11.19%
Literature References: Stable, efficient, and economic bromination reagent; alternative to bromine or NBS, q.q.v. Prepn: O. O. Orazi, J. Meseri, An. Asoc. Quim. Argent. 38, 5 (1950); I. Markish, O. Arrad, Ind. Eng. Chem. Res. 34, 2125 (1995). Analytical applications in determn of iodide, iodine values, propylthiouracil, and selenium sulfide: M. Hilp, S. Senjuk, J. Pharm. Biomed. Anal. 25, 363 (2001); idem, ibid. 28, 81, 303, 337 (2002). Use in aromatic bromination reactions: H. Eguchi et al., Bull. Chem. Soc. Jpn. 67, 1918 (1994); X. Herault et al., Org. Prep. Proced. Int. 27, 652 (1995); C. Chassaing et al., Tetrahedron Lett. 38, 4415 (1997); in oxidation of thiols: A. Khazaei et al., Synthesis 2004, 2959. Review of bromination chemistry: R. A. Reed, Chem. Prod. 23, 299-302 (1960); A. Alam, Synlett 2005, 2403-2404.
CAS Name: (3b,5a,22E,24R)-Stigmasta-7,22-dien-3-ol
Percent Composition: C 84.40%, H 11.72%, O 3.88%
Literature References: Stereoisomeric with a-spinasterol, q.v. Isolated from the green alga Scenedesmus obliquus (Turpin) Kuetz., Scenedesmaceae: Bergmann, Feeney, J. Org. Chem. 15, 812 (1950). Synthesis: W. Sucrow et al., Phytochemistry 15, 1533 (1976); M. Anastasia et al., J. Chem. Soc. Perkin Trans. 1 1981, 2561.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
